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Abstract
Background: Stilbenes are 1,2-diphenylethylene congeners produced by plants in response to
stress. Many stilbenes also exhibit xenobiotic activities in animal cells, such as inhibition of cancer
cell growth, neuroprotection, and immune modulation. In vivo, hydroxylated stilbenes are
metabolized by glucuronidation to facilitate excretion. Methoxylated stilbenes are metabolized
more slowly, which may have a positive effect on in vivo bioactivity. Here, we have directly
compared in vivo bioactivities of methoxylated and hydroxylated stilbenes in a whole organism using
the roundworm Caenorhabditis elegans, an advantageous experimental system for such studies due
to its rapid lifecycle, genetic amenability and relatively low-cost.
Results: Toxicity towards C. elegans adults was observed for trimethoxylated and dimethoxylated
stilbenes, as well as the monomethoxylated stilbene desoxyrhapontigenin. Toxicity was not
observed for the monomethoxylated stilbene, pinostilbene, nor for hydroxylated stilbenes. The
methoxylated stilbenes that exhibited toxicity also showed stronger inhibitory effects than the
hydroxylated stilbenes on germline tumor growth in gld-1(q485) adults. However, steady-state
levels of three inhibitory methoxylated stilbenes did not directly correlate to their relative
bioactivities.
Conclusion:  These findings demonstrate that, for the group of stilbenes investigated,
methoxylation generally increased bioactivity in vivo in a whole organism, with the exception of
pinostilbene. Differences in bioactivity in C. elegans adults did not appear to correlate with
differential uptake. Rather, we speculate that methoxylated stilbenes may have increased
interactions with biological targets in vivo or may interact with specific targets unaffected by
hydroxylated stilbenes. The potent activities of methoxylated stilbenes provide a basis for further
investigations to identify in vivo targets for these compounds.
Background
Phytochemicals induce an array of biological responses in
animal cells, including enzyme inhibition, protection
against oxidation and regulation of cellular signaling
pathways. Among phytochemicals with xenobiotic activi-
ties, the stilbenes are of great interest for their potential
medical impact. Stilbene compounds, particularly pter-
ostilbene and resveratrol, have been associated with anti-
Published: 13 August 2008
BMC Pharmacology 2008, 8:15 doi:10.1186/1471-2210-8-15
Received: 11 June 2008
Accepted: 13 August 2008
This article is available from: http://www.biomedcentral.com/1471-2210/8/15
© 2008 Wilson et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
Page 2 of 11
(page number not for citation purposes)
diabetic, anticarcinogenic and antilipogenic activities in
vitro  and  in vivo [1-4]. Specific enzymatic targets are
known for some of these xenobiotic activities. Pterostil-
bene and related compounds inhibit the cytochrome
P450 enzymes, CYP1A1 and CYP1B1, which induce carci-
nogenicity of environmental teratogens [5]. Pterostilbene
also inhibits cyclooxygenases COX-1 and COX-2, interfer-
ing with endocrine functions and supporting analgesic
activity [6]. Significant increase in activity of hexokinase,
while significant decrease in activity of glucose-6-phos-
phatase and fructose-1,6-bisphosphatase, were observed
after oral administration of pterostilbene in diabetic rats
[7]. The related compound, resveratrol, stimulates sirtuin
enzymes to promote longevity in response to dietary
restriction [8,9]. Resveratrol has also been demonstrated
to protect against obesity- and diet-related disease in
rodents [10]. Additional interactions with new targets
may be found to underlie other activities of these com-
pounds.
While dietary stilbenes and flavonoids are of particular
interest for their potential health benefits, in vivo activity
is limited by low bioavailability due to rapid metabolism
and excretion. Studies have found that methoxylation can
protect flavonoids from derivatization, thereby improving
biostability [11,12]. However, there is also evidence that
methoxylation can alter bioactivity. For example, methox-
ylated flavones induced different cell-cycle arrest points in
cultured human cells than hydroxylated flavones [13].
Thus, methoxylation may alter interactions with target
proteins, as well as increase bioavailability. These reports
on altered bioactivity in methoxylated flavonoids trig-
gered our interest to investigate the effects of methoxyla-
tion on stilbene bioactivity, particularly in a whole
organism, to assess effects on postmitotic cells in adult tis-
sues as well as on actively dividing cells.
Use of invertebrates provides one approach to address
these questions rapidly and economically in a whole
organism. In particular, the roundworm, Caenorhabditis
elegans, offers many advantages for such analyses. C. ele-
gans has a short generation time of 1 week and are easily
maintained in large numbers with ordinary laboratory
equipment. The adult body is approximately 1 mm in
length, and contains most of the tissues present in higher
vertebrates, such as a complete nervous system, striated
muscles and an intestine with digestive, detoxification
and innate immune functions. It is of note that the adult
somatic tissues are post-mitotic and therefore lack cell-
replacement capacity. C. elegans are hermaphrodites and
able to self-fertilize, which has greatly facilitated the
genetic analysis of developmental and cell biological
processes in this organism. Previous uses of C. elegans for
pharmacological studies have taken advantage of mutant
strains for mechanistic studies, in addition to basic studies
of compound-induced gene expression or phenotypic
changes [14-16].
In our study, we used C. elegans to compare the bioactivi-
ties of methoxylated and hydroxylated stilbenes, based on
the parent compound resveratrol. Seven stilbenes differ-
ing in hydroxylation and methoxylation patterns were
examined for effects on survival of fem-1(hc17)  sterile
adults and growth of germline tumors in gld-1(q485)
mutants. Methoxylated stilbenes exhibited greater bioac-
tivity in both assays, as compared with hydroxylated stil-
benes. Steady-state levels for three of these compounds
(one mono-, one di-, and one tri-methoxylated) were
measured in treated worms and were not found to corre-
late with relative bioactivity. This suggests that the greater
bioactivity of methoxylated stilbenes does not reflect dif-
ferential uptake of the compounds. These findings dem-
onstrate that methoxylation substitution enhances
stilbene bioactivity in this whole-organism model. Methyl
group-specific target site interactions may be one factor
accounting for the differential bioactivities of these com-
pounds. Alternatively, methoxylation may protect stil-
benes from metabolic modification and excretion,
leading to higher potency in vivo in C. elegans than hydrox-
ylated stilbenes.
Results and discussion
Seven methoxylated or hydroxylated stilbenes were com-
pared for effects on C. elegans survival and tumor growth.
This collection included two hydroxylated structures (res-
veratrol and piceatannol), two monomethoxylated struc-
tures (pinostilbene and desoxyrhapontigenin), two
dimethoxylated structures (3-hydroxy-5,4'-dimethoxystil-
bene and pterostilbene) and one trimethoxylated struc-
ture (resveratrol-trimethylether) (Figure 1). Bioactivity in
Structures of methoxylated and hydroxylated stilbenes  tested in this study Figure 1
Structures of methoxylated and hydroxylated stilbenes 
tested in this study.
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C. elegans has been reported only for resveratrol, which
extended adult lifespan [9]. It was of interest, therefore, to
compare adult survival in animals treated with resveratrol
and the related compounds.
For survival assays, young adult (day 0) animals were
transferred onto fresh medium supplemented with the
test compound at a range of concentrations. The com-
pounds were tested at indicated concentrations in the
growth medium (below). C. elegans nematodes are sur-
rounded by a thick collagenous cuticle and are therefore
relatively impermeable to environmental compounds.
Consistent with this, our measurements demonstrated
that internal concentrations of these compounds were sig-
nificantly lower than their concentrations in the medium.
Survival was scored every 2–3 days as the ability to move
in response to a gentle mechanical stimulus. During the
first week of adulthood, C. elegans hermaphrodites are
reproductively competent and normally produce 200–
300 progeny. Since progeny production would compli-
cate survival analysis, these experiments were performed
using fem-1(hc17) animals that are sterile due to a sperma-
togenesis defect [17,18]. Our prior analyses have con-
firmed that fem-1(hc17)  and wildtype animals have
similar lifespan characteristics [15].
Under our experimental conditions, both hydroxylated
and one monomethoxylated stilbene, pinostilbene, had
negligible or modestly beneficial effects on adult survival
(Figure 2). Consistent with previous reports, we observed
that resveratrol had a modestly beneficial effect on adult
lifespan (0–15% at 100 μM dose) (Table 1). However, the
effect was variable and did not attain statistical signifi-
cance in our experiments. In addition, piceatannol and
pinostilbene had beneficial effects on lifetime survival.
The effects of these compounds were also modest (5–
15%) and were not statistically significant.
The methoxylated stilbenes, desoxyrhapontigenin, 3-
hydroxy-5,4'-dimethoxystilbene, pterostilbene and resver-
atrol-trimethylether, each exhibited significant detrimen-
tal effects on adult survival (Figure 3). At a 100 μM dose
initiated on the first day of adulthood, survival was
reduced 11–26% by desoxyrhapontigenin, 48–57% by 3-
hydroxy-5,4'-dimethoxystilbene, 21–28% by pterostil-
bene and 18–51% by resveratrol-trimethylether (Table 1).
The toxicity of resveratrol-trimethyether increased steeply
within a relatively limited dose range, between 5–20 μM.
In contrast, the toxicity of desoxyrhapontigenin, 3-
hydroxy-5,4'-dimethoxystilbene and pterostilbene gradu-
ally increased between the 20–100 μM doses. The
observed difference in activity between the monomethox-
ylated stilbenes, desoxyrhapontigenin being toxic while
pinostilbene not, may be due to differences in steric hin-
derance introduced by the bulky methoxy groups at differ-
ent positions in the stilbene ring. Without knowing the
target site(s) in C. elegans for these stilbenes, it can be
speculated that the position of the methoxy group at ring
A in pinostilbene causes unfavourable fit for target site
inhibition. Differences in activity of these monomethoxy-
lated stilbenes have been demonstrated in other studies;
e.g., pinostilbene moderately inhibited the catalytic activ-
ity of cytochrome P450 2E1, while desoxyrhapontigenin
was not inhibitory [19]. We noted that animals treated
with either methoxylated or hydroxylated stilbenes did
not display any other noticeable phenotypes, such as
altered feeding or movement rates.
The somatic tissues of C. elegans adults are comprised
solely of post-mitotic cells and lack the ability to renew by
stem cell replacement. To more closely examine the effects
of methoxylated stilbenes on mitotically-active cells in
this organism, we examined their effects on growth of
germline tumors produced in gld-1(q485) animals. The C.
elegans hermaphrodite gonad is a U-shaped structure that
is bisymmetric and contains the germ cell pool (Figure 4A,
gld-1(+)). Within each gonad arm, germ cells in the distal
region undergo mitotic proliferation in response to Notch-
like signals produced by cells at the distal tips of the gonad
arms. As germ cells migrate along the gonad arm, they exit
from mitosis, undergo meiosis and subsequently differen-
tiate into mature oocytes. In gld-1(q485)  mutants, the
germ cells fail to exit from mitosis and continue to prolif-
erate throughout the gonad forming a germline tumor
that is lethal to the animal (Figure 4A, gld-1(q485))
[20,21].
Several stilbenes have demonstrated antiproliferative
effects on mammalian cancer cells in vitro [22-25]. To
assess the effects of methoxylation on antitumor activity
in vivo, tumor area was measured in gld-1(q485) adults
treated for four days with either resveratrol trimethylether,
desoxyrhapontigenin or pterostilbene, which are methox-
ylated and toxic to adults, or resveratrol, which is hydrox-
ylated and nontoxic. As controls, germline tumor area was
also measured in animals treated with carrier only (etha-
nol) or with 5-fluoro-2'-deoxyuradine (FUDR), a thymi-
dylate synthetase inhibitor that blocks cell proliferation
[26,27]. FUDR was chosen as a positive control for its
known antiproliferative effects in C. elegans, which have
been demonstrated by inhibition of embryonic and larval
development [28]. After four days of treatment, animals
were collected and germline tumors were visualized by
DAPI staining to visualize germcell nuclei. Because the
level of DAPI staining was not quantitative between ani-
mals, we DAPI signal intensity was not used as a measure
of tumor size. Rather, tumor size was directly measured as
the area of the DAPI-stained gonad.
For the initial tests of tumor growth suppression, each
compound was tested at a 100 μM dose in the growth
medium (Figure 4B). At this concentration, FUDR exhib-BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
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Table 1: Adult survival statistics for all trials.
Trial Concentration (μM) Mean lifespan (days) Relative survival (%) p (Logrank) n (failed, censor)
Treated Control
Resveratrol-trimethylether
1 100 9.7 12.16 80% 0.004 61,0
4 20 7.72 11.26 69% < 0.001 61,0
4 40 7.72 11.26 69% < 0.001 74,0
4 100 7.18 11.26 64% < 0.001 70,2
5 5 18.83 18.49 102% 0.91 46,3
5 20 16.41 18.49 89% 0.055 42,3
5 100 15.18 18.49 82% 0.005 37,6
6 20 9.02 15.32 59% < 0.0001 49,5
6 40 7.98 15.32 52% < 0.0001 51,0
6 100 7.54 15.32 49% < 0.0001 52,0
3-OH-5,4'- dimethoxystilbene
1 100 6.34 12.16 52% < 0.0001 53,0
2 20 11.05 11.05 100% 0.986 47,2
2 40 10.52 11.05 95% 0.234 40,1
6 20 10.38 15.32 68% < 0.0001 56,0
6 40 7.68 15.32 50% < 0.0001 54,1
6 100 6.56 15.32 43% < 0.0001 55,3
Pterostilbene
1 100 9.55 12.16 79% 0.005 69,9
4 20 10.43 11.26 93% 0.336 54,0
4 40 10 11.26 89% 0.035 65,1
4 100 8.07 11.26 72% < 0.0001 51,1
6 20 13.72 15.32 90% 0.058 55,1
6 40 14.41 15.32 94% 0.142 51,4
6 100 10.98 15.32 72% < 0.001 51,0
Desoxyrhapontigenin
1 100 10.64 12.16 88% 0.12 61,1
3 100 11.31 15.37 74% < 0.0001 36,0
3 200 11.61 15.37 76% < 0.0001 44,1
4 20 10.2 11.26 91% 0.12 74,0
4 40 10.38 11.26 92% 0.11 71,2
4 100 9.44 11.26 84% 0.003 50,0
6 20 14.18 15.32 93% 0.494 54,3
6 40 15.31 15.32 100% 0.48 59,1
6 100 13.63 15.32 89% 0.027 46,9
Pinostilbene
1 100 13.6 12.16 112% 0.062 68,1
2 20 10.04 11.05 91% 0.266 55,0
2 40 11.53 11.05 104% 0.319 42,5
3 100 16.9 15.37 110% 0.448 41,0
3 200 15.23 15.37 99% 0.411 42,5
6 20 14.24 15.32 93% 0.319 56,3
6 40 17.33 15.32 113% 0.085 60,0
6 100 16.24 15.32 106% 0.724 51,2BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
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ited a modest inhibitory effect on glp-1(q485) germline
tumor growth in two of three experiments (-4%, -7%, -
19%; p ≤ 0.05 for trials 2, 3, t-test vs untreated). At 100 μM
dose, the methoxylated stilbenes resveratrol trimethyl-
ether and desoxyrhapontigenin were also associated with
consistent reductions in tumor size. Pterostilbene also
modestly reduced tumor size, and this effect was statisti-
cally significant in 2 of 3 trials (p  ≤ 0.05, t-test vs
untreated). In contrast, resveratrol had a negligible effect
on gld-1(q485) germline tumor size which was not statis-
tically significant (-4%, p = 0.35). As expected from its
known antiproliferative effect, FUDR treatment also
appeared to decrease tumor size, although the effect was
statistically significant in only 2 of 3 trials.
To better quantify the effects of stilbenes and FUDR on
gld-1(q485) tumor growth, two stilbenes, resveratrol and
pterostilbene, and FUDR were examined at a series of
additional doses between 50–400 μM. Over this range of
concentrations, both FUDR and pterostilbene were associ-
ated with 10–20% reduction in tumor area (Figure 5A, B).
The effects of pterostilbene were somewhat variable
between trials, and were statistically significant for 3 of 4
experiments at both the 200 and 400 μM dose. The 200
and 400 μM doses of FUDR were consistently associated
with smaller tumor area and these effects were significant
in all 4 trials. Resveratrol at the 200 and 400 μM dose was
not associated with statistically significant reductions in
tumor area for any of the three trials conducted. These
data demonstrate that the enhanced bioactivity of meth-
oxylated stilbenes in vivo in C. elegans can be detected as a
reduction in glp-1(q485) tumor area as well as by adult
toxicity.
The differential bioactivities of methoxylated and hydrox-
ylated stilbenes in C. elegans adults might reflect differ-
ences in uptake or bioavailability. In general, intact C.
elegans adults take up compounds relatively poorly due to
their thick, impermeable cuticle. This impermeability has
impeded pharmacodynamic analysis in this organism.
However, steady-state levels of compounds can be meas-
ured in treated animals to provide one measure of phar-
macodynamics. To assess whether differential uptake
correlated with bioactivity in C. elegans, steady-state levels
for pterostilbene, resveratrol-trimethylether and desox-
yrhapontigenin were determined in animals treated for 2
days with 100 μM of each compound in the culture
medium. The levels of these stilbenes in C. elegans nema-
todes ranged from 20–80 μM, indicating relatively effi-
cient uptake (Figure 6). These concentrations were within
the range of serum stilbene levels detected after dietary
stilbene supplementation with human volunteers
(approx. 2 μM) and rabbits (42.8 μM) [29]. It is also
within the dose range where resveratrol was observed to
induce dilation of isolated retinal arterioles (50 μM) [30].
These three compounds, while all methoxylated, exhib-
ited different levels of toxicity in adult C. elegans. In
treated worms, levels of pterostilbene were slightly ele-
vated compared with resveratrol-trimethylether and des-
oxyrhapontigenin (Figure 6). However, the most toxic
compound in this group, resveratrol-trimethylether, was
present at less than one-third the level of pterostilbene.
These data suggest that relative bioactivity did not solely
reflect steady-state levels in intact animals, although, this
experiment does not directly compare the pharmacoki-
netic profile of each compound in C. elegans.
This study compared the effects of methoxylated and
hydroxylated stilbenes on adult lifespan and tumor
growth in C. elegans nematodes. In this organism, stilbene
methoxylation was associated with toxicity under chronic
treatment conditions and reduced tumor size in vivo.
Resveratrol
1 100 12.18 12.16 100% 0.867 70,3
2 20 11.85 11.05 107% 0.182 48,4
2 40 10.53 11.05 95% 0.924 55,0
3 100 16.64 15.37 108% 0.435 30,4
3 200 17 15.37 111% 0.337 38,0
6 20 14.65 15.32 96% 0.804 54,5
6 40 16.17 15.32 106% 0.501 59,0
6 100 17.55 15.32 115% 0.055 58,0
Piceatannol
2 20 11.72 11.05 106% 0.362 44,0
2 40 11.58 11.05 105% 0.5 37,9
3 100 17.78 15.37 116% 0.094 55,1
3 200 17.5 15.37 114% 0.166 55,1
6 20 13.71 15.32 89% 0.231 50,1
6 40 15.63 15.32 102% 0.75 50,1
6 100 16.6 15.32 108% 0.146 50,1
Table 1: Adult survival statistics for all trials. (Continued)BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
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Overall, this study corroborated other findings of
enhanced bioactivities in methoxylated versus hydroxy-
lated stilbenes in other experimental systems [31]. How-
ever, ours is the first study to systematically evaluate the
effects of stilbene methoxylation on bioactivity in a whole
organism, using C. elegans.
The mechanisms for enhanced bioactivity of methoxy-
lated stilbenes may reflect increased biostability in vivo
due to reduced efficiency of metabolic modification lead-
ing to excretion. In the case of another group of com-
pounds, the flavonoids, substituting the hydroxyl groups
with methoxy groups was shown to improve flavonoid
stability in cultured cells and liver microsomes by block-
ing metabolic modification and excretion [12,11]. In
mammals, hydroxylated flavonoids were shown to
undergo glucuronidation by hepatic enzymes to promote
excretion [11]. Thus, methoxylation may block this mod-
ification and may also promote biostability. Indeed, one
naturally methoxylated stilbene, pterostilbene, is cyto-
toxic in several cellular systems [32]. In contrast, the
hydroxylated stilbene, resveratrol, has also been shown to
be cytotoxic, but is poorly retained in plasma compared
with pterostilbene [33]. Thus, methoxylation differences
between pterostilbene and resveratrol may improve bio-
activity by increasing in vivo stability.
The basis for the toxicity and antiproliferative activities of
methyoxylated stilbenes in C. elegans adults is not known.
The somatic cells of C. elegans adults are entirely postmi-
totic, ruling out antiproliferative effects as the basis for
methoxylated stilbene toxicity. However, the toxicity and
antitumor activities of methoxylated stilbenes in C. ele-
gans adults may reflect interactions with common biolog-
Hydroxylated and one monomethoxylated stilbene had mod- est beneficial effects on adult C. elegans survival Figure 2
Hydroxylated and one monomethoxylated stilbene 
had modest beneficial effects on adult C. elegans sur-
vival. (A, C, E) Representative survival curves of adult sterile 
fem-1(hc17) animals treated with indicated doses of each 
compound or vehicle in the medium. Experiments for each 
compound were conducted concurrently for all doses 
shown. (B, D, F) Summary data from n = 1–3 independent 
experiments per concentration tested, showing dose-
response for each compound. Complete survival statistics 
are presented in Table 1.
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ical targets. Studies in other experimental systems show
that stilbenes are potent antioxidants [34,35]. However,
resveratrol and pterostilbene, which have strikingly differ-
ent activity in vivo in adult C. elegans, demonstrated simi-
lar antioxidant activity in vitro, suggesting that antioxidant
activity is not the underlying reason for the difference in
stilbene bioactivities in C. elegans. Stilbenes are also
known to inhibit specific cellular enzymes, such as cyto-
chrome P450 and COX enzymes. One study has com-
pared the relative inhibition of mammalian CYP1
cytochrome P450 enzymes by pterostilbene, pinostilbene
and desoxyrhapontigenin [5]. In this study, these three
methoxylated stilbenes demonstrated increased CYP1
inhibition relative to resveratrol, in partial agreement with
our results. However, pinostilbene demonstrated slightly
stronger CYP1 inhibition than pterostilbene and desox-
yrhapontigenin, a finding not consistent with our C. ele-
gans  toxicity data. Stilbenes also inhibit COX-1 and -2
monooxygenases. C. elegans nematodes do not have any
obvious COX-1 or -2 homologs, although the C. elegans
genome sequence does contain numerous monooxygen-
ases that might have similar mechanisms of action to
mammalian COX-1 and -2 enzymes. Further characteriza-
tion of the in vivo targets for methyoxylated stilbenes in C.
elegans  may provide insight into other bioactivities of
these compounds in human cells.
Conclusion
Stilbene methoxylation was associated with increased in
vivo bioactivity as tested by toxicity and tumor growth in
C. elegans. In general, increasing degree of methoxylation
was correlated with increasing bioactivity, with the excep-
tion of pinostilbene. However, methoxylation and toxic-
ity were not correlated with steady-state levels of these
compounds in treated animals. These findings suggest
that methoxylation enhances bioactivity possibly through
increased interactions with in vivo targets. A working
hypothesis to account for these results is that stilbene
methoxylation protects the compound from conjugation
and subsequent excretion, thereby increasing biostability
and bioavailability in C. elegans.
Methods
C. elegans strains and culture conditions
C. elegans strains were maintained at 15°C on NGM agar
medium with a live, slow-growing OP50 bacterial lawn
for a food source following standard protocols [36]. The
following mutant strains were used in this study: BA17,
fem-1(hc17), and JK1466, gld-1(q485)/dpy-5(e61) unc-
13(e51). Strains were obtained from the Canorhabditis
Genetics Center at the University of Minnesota.
Chemical sources and methoxylated stilbene preparation
Resveratrol and picetannol were obtained from commer-
cial sources (Sigma-Aldrich, Inc. and Calbiochem-Novo-
biochem Corp., respectively). The methoxylated stilbenes
pinostilbene, desoxyrhapontigenin, 3-hydroxy-5,4'-
dimethoxystilbene and pterostilbene (Figure 1) were syn-
thesized by partial methylation of trans-resveratrol as pre-
viously reported [34]. The methoxylated stilbenes were
purified by preparative layer chromatography (Merck Sil-
ica gel 60 F254; EMD Chemicals Inc., Gibbstown, NJ)
using the developing solvent chloroform:methanol (96:4)
Methoxylated stilbenes, desoxyrhapontigenin and resvera- trol-trimethyether, demonstrated modest anti-tumor activity  in vivo Figure 4
Methoxylated stilbenes, desoxyrhapontigenin and 
resveratrol-trimethyether, demonstrated modest 
anti-tumor activity in vivo. (A) Upper right, cartoon of 
normal germ cell proliferation and differentiation in gld-1(+) 
animals. Below, cartoon of aberrant germline tumors formed 
in gld-1(q485) animals. In tumor-containing glp-1(q485) adults, 
DAPI staining allows visualization and quantification of germ-
line tumors as the fluorescent area filling the body. (B) Mean 
germline tumor size (area ± SEM) relative to control in glp-
1(q485) adults treated with 100 μM doses of indicated stil-
benes or FUDR. Results are average from at least 3 inde-
pendent experiments. In each experiment, tumor area was 
determined for 12–47 individuals per compound (average ± 
SD = 23.1 ± 10.12 animals). Significance was judged in paired 
t-test (2-tailed); * p < 0.05 versus untreated.
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FUDR
Resveratrol
Desoxy-
rhapontigenin
Pterostilbene
Resveratrol-
trimethylether
Relative tumor size
0 0.5 1
B
*
*
A mitotic
region
meiotic
region
oocytes sperm
X X X X
X X X
X
X
X X X
X X X
fertilized embryo
gld-1(+)
gld-1(q485)BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
Page 8 of 11
(page number not for citation purposes)
with 1% formic acid. The Rf values for pterostilbene, 3-
hydroxy-5,4'-dimethoxystilbene, pinostilbene and desox-
yrhapontigenin are 0.61, 0.57, 0.28, and 0.20, respec-
tively. These stilbenes were identified from their 1H-NMR
spectra (Bruker 400 MHz; Bruker, Billerica, MA). All stil-
benes were dissolved in ethanol to 25 mg/mL before use.
5-Fluoro-deoxyuracil (Sigma Chemical Co.) was dis-
solved to 1 mg/mL in sterile water and stored frozen at -
20°C until use. For treating C. elegans adults, each com-
pound was added in a 200 μL volume to the top of a 1-day
old bacterial lawn grown on NGM medium to final con-
centrations as indicated. Compounds were allowed 2
hours to diffuse through the agar medium before animals
were added.
Survival assays
For survival analyses, synchronized populations of sterile
fem-1(hc17) hermaphrodites were obtained by first trans-
Titration of germline tumor growth suppression by FUDR, resveratrol and pterostilbene Figure 5
Titration of germline tumor growth suppression by FUDR, resveratrol and pterostilbene. (A) Representative 
images of DAPI-stained glp-1(q485) animals treated for four days with 100 μM or 400 μM doses of FUDR, resveratrol and pter-
ostilbene. The inhibitory effect of FUDR and pterostilbene on tumor size is particularly evident near the central region of the 
animal where the reflexed arms of the distal gonad meet (arrow in (a), (c) and (e)). (a, h) vehicle-treated controls. (h) is from 
the same experimental series as (c); (a) is from the same experimental series as other images; (b, c), FUDR at 100 μM (b) and 
400 μM (c); (d, e), pterostilbene at 100 μM (d) and 400 μM (e); (f, g) resveratrol at 100 μM (f) and 400 μM (g). Scale bar = 250 
μM. (B) Summary of results from three independent experiments for each compound at indicated doses. Each concentration 
was tested in at least 3 independent trials and a total of 36–100 animals were measured per compound dose in all experiments. 
Significance was judged by a paired t-test (2-tailed); *, #, ^ p < 0.05 versus untreated for FUDR-, pterostilbene- or resveratrol-
treated animals, respectively.BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
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ferring several fertile hermaphrodites to a fresh plate at
25°C and allowing them to lay eggs for several hours. The
parent hermaphrodites were removed and embryos were
allowed to develop into sterile adults at 25°C, which takes
approximately 48 hours [17]. On the first day of adult-
hood, referred to as day 0, sterile adults were transferred
onto fresh media supplemented with stilbenes at indi-
cated concentrations, and maintained at 25°C. Adult sur-
vival was scored every 2–3 days by the animal's ability to
move in response to a gentle mechanical stimulus. Statis-
tical analysis of survival was performed using the JMP
software package.
Germline tumor growth assays
The gld-1(q485) mutation causes a defect in oocyte devel-
opment that results in growth of germline tumors that fill
the somatic gonad, eventually leading to the animal's
death [20,21]. To examine the effects of the stilbenes on
gld-1(q485) germline tumors, day 0 adults were placed on
stilbene-containing medium in the presence of OP50 bac-
teria as food source. After 4 days at 20°C, animals were
fixed in methanol and germcell nuclei were visualized by
staining with DAPI. Images were collected with the entire
animal in view using the 4× objective on a Nikon E800
microscope equipped with a Hamamatsu Orca ER CCD
camera using OpenLab imaging software. NIH Image J
software was used to measure germline tumor growth in
treated and untreated animals. Tumor area was measured
by outlining the entire DAPI-stained tumor.
Determination of stilbene uptake
Uptake was determined for three stilbenes (desox-
yrhapontigenin, pterostilbene and resveratrol-trimethyl-
ether) by measuring the steady-state levels of each stilbene
in adult fem-1(hc17) hermaphrodites treated under the
same conditions as those used for survival assays. After a
2-day treatment on stilbene-supplemented medium, ani-
mals were collected into eppendorf tubes, washed with
sterile M9 and allowed to settle under a minimal volume
of liquid. The samples were frozen at -80°C for storage.
For the analysis of stilbenes, samples were thawed in ice
and homogenized in 300 μL of 0.2 M phosphate buffer
then centrifuged (4°C, 4000 rpm, 15 min). The superna-
tant was collected and the pellet was homogenized further
with fresh 300 μL of 0.2 M phosphate buffer then centri-
fuged. The supernatants were combined and loaded on an
Oasis® HLB solid phase extraction cartridge (Waters Cor-
poration, Milford, MA) that has been preconditioned with
0.2 M phosphate buffer. The stilbenes were eluted with 2
mL of methanol and collected in a vial. The eluate was
dried under a stream of nitrogen, redissolved in 1 mL of
ethyl acetate, filtered (0.2 μm nylon filter) then dried
again under a stream of nitrogen. The dried sample was
treated with 30 μL of N,O-bis [trimethylsilyl]trifluoroa-
cetamide:dimethylformamide (BSTFA: DMF, 1:1; Pierce
Biotechnology, Inc., Rockford, IL) and heated at 70°C for
45 min. Derivatized sample was analyzed for stilbenes by
gas chromatography-mass spectrometry (GC-MS). GC-MS
was performed on a JEOL GCMate II spectrometer (JEOL
USA Inc., Peabody, MA) in tandem with an Agilent 6890N
gas chromatograph (Agilent Technologies, Santa Clara,
CA) using a J&W DB-5 capillary column (0.25 mm inter-
nal diameter, 0.25 μm film thickness, 30 m length; Agilent
Technologies). The GC temperature program was: initial
190°C, increased to 240°C at 25°C/min rate and held at
this temp for 14 min, then finally increased to 300°C at
the rate of 25°C/min and held at this temperature for 1
min. The carrier gas was ultrahigh purity helium, at 1 mL/
min flow rate. The injection port, GC-MS interface and
ionization chamber were at 250, 230 and 230°C, respec-
tively. The volume of injection was 1 μL, splitless injec-
tion. Mass spectrum was acquired in positive, electron
impact (70 eV), selected ion monitoring mode. Resvera-
trol-trimethylether (retention time 10.6 min) was moni-
tored at m/z  270, 239 and 196; desoxyrhapontigenin
(retention time 13.1 min) was monitored at m/z 328, 313
and 206; pterostilbene (retention time 13.6 min) was
Steady-state levels of three stilbene compounds in treated C.  elegans adults did not correlate with toxicity Figure 6
Steady-state levels of three stilbene compounds in 
treated C. elegans adults did not correlate with toxic-
ity. Animals were treated for two days with a toxic dose 
(100 μM) of indicated compound in the medium. After col-
lection, stilbene levels determined as described in methods. 
Compounds were measured in two independent samples for 
each treatment with paired negative control. Averages and 
SDs between both measurements are shown; statistical sig-
nificance was determined by t-test.
0
20
40
60
80
100
Resveratrol-
trimethylether Desoxy-
rhapontigenin
Pterostilbene
C
.
 
e
l
e
g
a
n
s
 
s
t
i
l
b
e
n
e
 
l
e
v
e
l
 
(
μ
M
)
(
4
8
 
h
o
u
r
 
t
r
e
a
t
m
e
n
t
 
@
1
0
0
 
μ
M
)
p=0.04
p=0.18
p=0.06BMC Pharmacology 2008, 8:15 http://www.biomedcentral.com/1471-2210/8/15
Page 10 of 11
(page number not for citation purposes)
monitored at m/z 386, 371 and 297. Quantitation was
performed from calibration curve of authentic stilbene
samples. GC-MS analyses were in duplicates. For conver-
sion from pg/worm to molarity concentration in vivo, the
volume of a wildtype hermaphrodite on day 4 of adult-
hood was taken to be 4.5 μL, as previously determined
[37].
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